Potential gastrointestinal Behcet’s disease flare after treatment with anti-interleukin 17a therapy

BACKGROUND: Behcet’s disease (BD) is a systemic disease characterized by recurrent oral and genital ulcers. The underlying disease pathway likely involves interleukin (IL)-17 A, a proinflammatory cytokine that is implicated in Behcet’s uveitis. Secukinumab is an anti-IL-17 A drug that may have an em...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Frances Sze Kei, Chiu, Nicole Sau Yan, Chung, Ho Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408212/
https://www.ncbi.nlm.nih.gov/pubmed/37553722
http://dx.doi.org/10.1186/s41927-023-00344-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408212/
https://www.ncbi.nlm.nih.gov/pubmed/37553722
http://dx.doi.org/10.1186/s41927-023-00344-9

Ejemplares similares